Table 2.

Distributions of CD14 -159c/T polymorphism genotypes and alleles among cancer patients and controls

Author	Case			Control			Case		Control		HWE
	TT	CT	CC	TT	CT	CC	T	C	T	C	P-value
Andrie et al14	13	39	31	23	42	18	65	101	88	78	0.89
Castaño-Rodríguez et al15	14	38	18	72	108	34	66	74	252	176	0.54
Guo et al16	41	34	35	58	77	25	116	104	193	127	0.95
Hold et al17	83	134	110	82	176	131	300	354	340	438	0.11
Hold et al17,*	68	147	91	51	108	52	283	329	210	212	0.73
Hold et al17,*	34	74	50	51	108	52	142	174	210	212	0.73
Landi et al18	68	151	62	63	137	65	287	275	263	267	0.58
Tahara et al19	32	80	37	27	53	14	144	154	107	81	0.15
Wu et al20	24	29	17	54	102	54	77	63	210	210	0.68
Wu et al20,*	50	102	52	54	102	54	202	206	210	210	0.68
Yu et al21	90	55	29	200	259	80	235	113	659	419	0.80
Zhao et al22	212	225	33	187	227	56	649	291	601	339	0.30

Note:

^*Different cancers were studied in one publication and each was treated to a separate analysis.

Abbreviations: C, cytosine; CD, cluster of differentiation; T, thymine; HWE, Hardy–Weinberg equilibrium.